Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review

Cardiovascular (CV) events in patients with cancer can be caused by concomitant CV risk factors, cancer itself, and anticancer therapy. Since malignancy can dysregulate the hemostatic system, predisposing cancer patients to both thrombosis and hemorrhage, the administration of dual antiplatelet ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsigkas, Grigorios, Vakka, Angeliki, Apostolos, Anastasios, Bousoula, Eleni, Vythoulkas-Biotis, Nikolaos, Koufou, Eleni-Evangelia, Vasilagkos, Georgios, Tsiafoutis, Ioannis, Hamilos, Michalis, Aminian, Adel, Davlouros, Periklis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144375/
https://www.ncbi.nlm.nih.gov/pubmed/37103014
http://dx.doi.org/10.3390/jcdd10040135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144375/
https://www.ncbi.nlm.nih.gov/pubmed/37103014
http://dx.doi.org/10.3390/jcdd10040135

Ejemplares similares